PER-063-01已完成未知
A Prospective, Multicenter, Open-Label, Randomized, Comparative Study to Evaluate the Efficacy, Safety, and Tolerability of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-Abdominal Infections in Adults
MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 0 人开始时间: 2001年10月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •-Male or female patients age 18 or older
- •-Patient has a diagnosis of intra-abdominal infection requiring surgery as evidenced by fever, elevated while blood cell count and abdominal pain
排除标准
- •- Patient has another infection, other than abdominal
- •- Female patient is pregnant or planning to become pregnant
研究者
相似试验
已完成
不适用
Ertapenem versus Ceftriaxone and Metronidazole As Treatment For Complicated Intra-abdominal InfectionsComplicated intra-abdominal infectionsInfections and InfestationsOther and unspecified infectious diseasesISRCTN59616541Merck and Co., Inc. (USA)500
Unknown
不适用
A clinical study to check the effect medicine to control the Diarrhea in children.CTRI/2019/06/019838Dr Vijay Yewale
进行中（未招募）
1 期
A Study to Compare the Efficacy and Safety of a Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) Versus Obinutuzumab and Chlorambucil in Previously Untreated Patients with CLL and Coexisting Medical ConditionsCTIS2023-504034-22-00F. Hoffmann-La Roche AG397
进行中（未招募）
1 期
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine and Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) without DEL (17P) or TP53 mutatioChronic Lymphocytic Leukemia (CLL)MedDRA version: 21.0Level: LLTClassification code: 10008976Term: Chronic lymphocytic leukemia Class: 10029104CTIS2023-504036-17-00F. Hoffmann-La Roche AG166
招募中
2 期
Study of the effect of Siddha Treatment in addition to standard therapy in COVID-19 patientsCTRI/2020/06/025625Eminentlabs Business Solutions Pvt Ltd